Covid may trigger diabetes in healthy people: Study

| | New Delhi
  • 0

Covid may trigger diabetes in healthy people: Study

Sunday, 14 June 2020 | PNS | New Delhi

That Covid-19 causes severe complication to those suffering from diabetes is a known fact. But now there are emerging evidences that suggest that the virus may actually trigger the onset of the non-communicable disease in a healthy person.

An international group of 17 leading diabetes experts involved in the CoviDiab Registry project, a collaborative international research initiative, have announced the establishment of a Global Registry of new cases of diabetes in patients with Covid- 19.

The Registry aims to understand the extent and the characteristics of the manifestations of diabetes in patients with Covid-19, and the best strategies for the treatment and monitoring of affected patients, during and after the pandemic, said a letter published in the New England Journal of Medicine.

Clinical observations so far show a bi-directional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with increased risk of Covid-19 severity and mortality. Between 20 and 30 per cent of patients who died with Covod-19 have been reported to have diabetes. On the other hand, new-onset diabetes and atypical metabolic complications of pre-existing diabetes, including life-threatening ones, have been observed in people with Covid-19.

It is still unclear how SARS-Cov-2, the virus that causes Covid-19, impacts diabetes. Previous research has shown that ACE-2, the protein that binds to SARS-Cov-2 allowing the virus to enter human cells, is not only located in the lungs but also in organs and tissues involved in glucose metabolism such as the pancreas, the small intestine, the fat tissue, the liver and the kidney.

Researchers hypothesise that by entering these tissues, the virus may cause multiple and complex dysfunctions of glucose metabolism. It has also been known for many years that virus infections can precipitate type 1 diabetes.

Francesco Rubino, Professor of Metabolic Surgery at King's College London and co-lead investigator of the CoviDiab Registry project, said: "Diabetes is one of the most prevalent chronic diseases and we are now realizing the consequences of the inevitable clash between two pandemics. Given the short period of human contact with this new coronavirus, the exact mechanism by which the virus influences glucose metabolism is still unclear and we don't know whether the acute manifestation of diabetes in these patients represent classic type 1, type 2 or possibly a new form of diabetes".

Paul Zimmet, Professor of Diabetes at Monash University in Melbourne and co-lead investigator in the CoviDiab Registry project said: "We don't yet know the magnitude of the new onset diabetes in Covid-19 and if it will persist or resolve after the infection; and if so, whether or not or Covid-19 increases risk of future diabetes.

“By establishing this Global Registry, we are calling on the international medical community to rapidly share relevant clinical observations that can help answer these questions".

Stephanie Amiel, Professor of Diabetes Research at King's College London and a co-investigator of the CoviDiab Registry project further explained that the registry focuses on routinely collected clinical data that will help us examine insulin secretory capacity, insulin resistance and autoimmune antibody status to understand how Covid-19 related diabetes develops, its natural history and best management. Studying Covid-19-related diabetes may uncover novel mechanisms of disease."

Sunday Edition

CAA PASSPORT TO FREEDOM

24 March 2024 | Kumar Chellappan | Agenda

CHENNAI EXPRESS IN GURUGRAM

24 March 2024 | Pawan Soni | Agenda

The Way of Bengal

24 March 2024 | Shobori Ganguli | Agenda

The Pizza Philosopher

24 March 2024 | Shobori Ganguli | Agenda

Astroturf | Lord Shiva calls for all-inclusiveness

24 March 2024 | Bharat Bhushan Padmadeo | Agenda

Interconnected narrative l Forest conservation l Agriculture l Food security

24 March 2024 | BKP Sinha/ Arvind K jha | Agenda